Invivyd (IVVD) Operating Expenses (2021 - 2026)

Invivyd (IVVD) has reported Operating Expenses for 6 consecutive years, with $60.1 million the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Operating Expenses rose 123.89% year-over-year to $60.1 million; the trailing twelve-month figure through Jun 2026 stood at $140.9 million (down 11.81% YoY), and the FY2025 full-year result was $109.0 million, down 46.12% from the prior year.
• Operating Expenses rose to $60.1 million in Q2 2026 per IVVD's latest filing, from $29.8 million in the prior quarter.
• Across five years, Operating Expenses topped out at $100.7 million in Q1 2022 and bottomed at $24.2 million in Q3 2025.
• Historically, Operating Expenses has averaged $48.9 million across 5 years, with a median of $47.3 million in 2022.
• The sharpest annual moves came in 2022 and 2025: Operating Expenses jumped 160.25% in 2022, then tumbled 66.27% in 2025.
• Over 5 years, Operating Expenses stood at $48.2 million in 2022, then jumped by 59.2% to $76.8 million in 2023, then slumped by 56.94% to $33.0 million in 2024, then fell by 9.95% to $29.8 million in 2025, then jumped by 101.95% to $60.1 million in 2026.
• According to Business Quant data, Operating Expenses over the past three periods registered $60.1 million, $29.8 million, and $24.2 million for Q2 2026, Q4 2025, and Q3 2025 respectively.